DNLI Chart
See on advanced chart >
About
Denali Therapeutics Inc. was incorporated in Delaware in October 2013. Their goal is to discover and develop therapeutics to defeat degeneration.Neurodegeneration represents one of the most significant unmet medical needs of their time, with few effective...
Read More
- HighlightA biopharmaceutical company that develops a broad portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases
- ExchangeNASDAQ
- Listing Date12/08/2017
- Established DateInvalid Date
- Full-time Employees445
- Address161 Oyster Point Blvd South San Francisco CA 94080
- Tel1-650-8668548
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology